about
Current Management of Alcoholic Hepatitis and Future TherapiesComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries"Weighing the risk": Obesity and outcomes following liver transplantationControversies in the Mechanism of Total Parenteral Nutrition Induced PathologyReview article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseApplication of glycoscience to the early detection of pancreatic cancerDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewDisruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and InflammationHepatic mitochondrial function analysis using needle liver biopsy samplesGallstones in Patients with Chronic Liver Diseases.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats.Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.Inflammation in nonalcoholic steatohepatitis.Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models.Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisIs MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factorsPediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function.Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic PatientsNon-alcoholic fatty liver disease in 2015.Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol.Glycogenic Hepatopathy: Thinking Outside the BoxThe Role of miR-212 and iNOS in Alcohol-Induced Intestinal Barrier Dysfunction and SteatohepatitisFluoride Intensifies Hypercaloric Diet-Induced ER Oxidative Stress and Alters Lipid Metabolism.High Intrinsic Aerobic Capacity Protects against Ethanol-Induced Hepatic Injury and Metabolic Dysfunction: Study Using High Capacity Runner Rat Model.Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy.Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity.Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats.Expanded criteria donors.Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
P2860
Q26746544-8C757002-E6D6-49D8-9049-748AEBCE0B27Q26828855-CEE4307D-F59C-4375-9685-A810F6E57CCBQ26859205-2D839ADC-9D7B-4632-938C-3E8B6B5C925AQ26865276-3205EE5F-C35E-47B2-9444-E36FF7C65FEDQ26998093-D0E0ECD5-66A0-41C2-A31A-2D725CEA9857Q27005988-B61D963A-5B8F-40A9-BBD7-A1F11E16A11AQ28066814-964AC016-FBF7-4526-A60E-FEBBBABABA71Q28070408-F358ED34-D202-4AF1-A68D-EA7029DA9E6CQ28534128-007C8525-19D5-4DEE-A35B-5925872B8487Q28534697-0C0F297B-5EDA-4E0F-8A39-1C40DFFAF642Q30235500-3D369968-BE0A-4BF8-B5CD-051DA1189837Q30355082-4BFA9123-356C-4B97-9369-14E95BDA19E7Q30389180-1131329A-86A2-4B0D-A3B1-55A59944C047Q30433234-A64F1296-CCAA-4F52-9327-B4F309A1BF52Q30453231-6DAD5F6E-5C9D-4CF4-B7F7-37C00FA40948Q30877287-F0E6A7EF-7856-4FBB-B487-214BDE8417D7Q33569937-617959D4-11D0-4F9B-97CE-546106F9C543Q33751826-2FF9548C-1850-434B-8F70-E4708D6C7ADBQ33844960-92509858-35D5-4FCE-BA90-FA7862975965Q34185231-99185F45-D7BB-4580-AC67-9723935067C8Q34499029-F82781D4-6D9F-4B12-984A-41F9B8A77E9DQ34575945-492A1A41-743E-45E8-AD86-F92CA8C64F56Q34785324-FECAC81E-BAC6-4E29-97E5-B4B56251E588Q35025292-25842D2A-05DC-4D20-A31F-F8B038E693BEQ35157367-7C4B5CE3-A6DC-4DB8-A5E5-E89E93250179Q35580023-09F038E1-052E-4166-AD1C-559934F3080FQ35592598-98768919-D606-4956-ABBE-F7ADF5C77FD1Q35715883-3440F421-D915-463F-9606-E9E7146370E3Q35895832-FF3D6810-D465-4427-93E3-DBA4F4A6213CQ35903167-AE4126C2-55A0-4673-87D5-83E531F6CBB3Q36021666-5D79B7B7-372C-4D82-847D-E6B6C5580A92Q36059903-609633BB-C619-43D6-B299-502F7742AE81Q36409609-BC053DD7-C1FD-44BD-9CFB-B1BE58358818Q36411014-EE80B44F-C6BF-4069-815A-D8A21C15FF1AQ36493910-3542C468-E10A-4824-A8A1-06A762BD0C8AQ36561556-B37934F5-CCCB-4E6A-9A63-17FF946FA9E2Q36642354-45BA78F7-927D-4570-9188-7CC707F8CD2AQ36657068-69F83FFD-BDE6-431D-835D-52EA1F8474ABQ36733650-544D879D-6012-4C46-8500-F46987B5A434Q36864507-90FD5D05-BB42-4106-A5FC-BC02300E1836
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Histopathology of nonalcoholic fatty liver disease.
@ast
Histopathology of nonalcoholic fatty liver disease.
@en
Histopathology of nonalcoholic fatty liver disease.
@nl
type
label
Histopathology of nonalcoholic fatty liver disease.
@ast
Histopathology of nonalcoholic fatty liver disease.
@en
Histopathology of nonalcoholic fatty liver disease.
@nl
prefLabel
Histopathology of nonalcoholic fatty liver disease.
@ast
Histopathology of nonalcoholic fatty liver disease.
@en
Histopathology of nonalcoholic fatty liver disease.
@nl
P2860
P356
P1476
Histopathology of nonalcoholic fatty liver disease.
@en
P2093
Dina G Tiniakos
Elizabeth M Brunt
P2860
P304
P356
10.3748/WJG.V16.I42.5286
P407
P577
2010-11-01T00:00:00Z